Bridgeway Capital Management, LLC Veracyte, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 199,400 shares of VCYT stock, worth $8.98 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
199,400
Previous 199,400
-0.0%
Holding current value
$8.98 Million
Previous $4.32 Million
57.06%
% of portfolio
0.15%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding VCYT
# of Institutions
316Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$351 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$349 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$226 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$222 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$191 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.23B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...